Palvella Therapeutics, Inc. (PVLA) /
The revenue of Palvella Therapeutics, Inc. over the past 10 years
Chart Palvella Therapeutics, Inc.: revenue, fiscal 2016–2025 Open the chart →Palvella Therapeutics, Inc. reported revenue of $42.81M in fiscal 2023. In fiscal 2016 it was $5.83M — up 634% over 7 years. Year over year, revenue rose 5 times and fell twice. In these years the highest was $46.28M in fiscal 2019. The largest one-year move was in fiscal 2017: up 333%, from $5.83M to $25.27M. No revenue figure is on file for fiscal 2024 and 2025.
Year by year
| Fiscal year | Revenue |
|---|---|
| 2025ended Dec 31, 2025 | — |
| 2024ended Dec 31, 2024 | — |
| 2023ended Dec 31, 2023 | $42.81M |
| 2022ended Dec 31, 2022 | $25.9M |
| 2021ended Dec 31, 2021 | $31.42M |
| 2020ended Dec 31, 2020 | $29.32M |
| 2019ended Dec 31, 2019 | $46.28M |
| 2018ended Dec 31, 2018 | $29.1M |
| 2017ended Dec 31, 2017 | $25.27M |
| 2016ended Dec 31, 2016 | $5.83M |
Fiscal years as Palvella Therapeutics, Inc. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on Palvella Therapeutics, Inc.
- The profitability of Palvella Therapeutics, Inc.
- The cash flow of Palvella Therapeutics, Inc.
- The debt of Palvella Therapeutics, Inc.
- All of Palvella Therapeutics, Inc.'s financials, charted
Companies of a similar size
- NEOGNeogen Corporation
- PHINPHINIA INC.
- BBTBeacon Financial Corp
- WLYJOHN WILEY & SONS, INC.
- FCPTFour Corners Property Trust, Inc.
Not investment advice. This page shows what Palvella Therapeutics, Inc. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.